Interestingly, IL-17 production is reduced in patients with active tuberculosis and its production increases when tuberculosis symptoms are ameliorated after drug treatment, to levels found in healthy controls (31–33), suggesting that IL-17 may participate for the control of mycobacterial infections. Here, IL17A is linked to tuberculosis.